71 results
8-K
EX-1.1
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock
424B5
ALRN
Aileron Therapeutics Inc
1 May 24
Prospectus supplement for primary offering
5:24pm
, before expenses, to us
Underwriting discounts and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed
8-K
EX-10.4
4dfsglyiddxte
25 Jan 24
Other Events
7:00am
8-K
EX-10.5
pbvhfq
25 Jan 24
Other Events
7:00am
8-K
EX-10.1
mdmd0
25 Jan 24
Other Events
7:00am
8-K
tyl ghj3iiv5
25 Jan 24
Other Events
7:00am
8-K/A
EX-99.2
bfw7dgmyiyo6ig
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K/A
EX-99.1
qq0 r24dr13
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K
EX-10.3
f11en2j
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm